EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic significance of peripheral blood inflammatory biomarkers (SII, PLR, NLR, LMR, SIRI, PIV, PNI) in lip cancer: NLR as an independent biomarker for survival outcomes

Zhilin Li, Wei An, Bin Wang, Zening Yan, Liangbin Gao, Jiaming Wang, Hongmei Yu, Shuxin Wen

Frontiers in Oncology · 21.10.2025 · 15

DOI: 10.3389/fonc.2025.1676824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 21.10.2025. Verfasst von Zhilin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical Uni…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanxi Province, Health Commission of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lip cancer is a type of oral cancer with a different prognosis than that of other cancers. However, a lack of well-established understanding of the relationship between the peripheral blood inflammatory biomarker (PBIB) and prognosis in patients with lip cancer is evident. This study investigated the prognostic value of inflammatory markers and other unfavourable prognostic factors. It compares the systemic immune-inflammation index (SII), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR), systemic inflammation response index (SIRI), pan-immune-inflammation value (PIV) and prognosis nutritional index (PNI) in patients with lip cancer. Materials and methods This retrospective study included 122 patients with lip cancer. Clinical characteristics and hematological parameters were retrospectively obtained prior to treatment. SII, PLR, NLR, LMR, SIRI, PIV and PNI were calculated to analyze their effects on survival and recurrence further.

Results

Receiver operating characteristics curve analysis demonstrated SII >534.286, PLR >146.528, NLR >2.134, LMR ≤4.000, SIRI >0.7100, PIV >211.930, PNI ≤51.900 were factors associated with increased mortality. Univariate analysis showed that these inflammatory parameters were associated with a lower survival rate. In multivariate analysis, NLR was identified as having a cumulative role in predicting overall survival (HR=5.885, 95% CI: 2.131–16.256, P <0.001).

Conclusion

This study revealed that NLR is a promising blood biomarker in patients with lip cancer. The predictive power of other PBIBs, albeit showing a trend towards significance, were not statistically significant, possibly due to the limited number of cases. The clinical applicability of other hematological indicators requires further study.

Schlagwörter

Stichwörter der Autor:innen

lip cancerneutrophil-lymphocyte ratio (NLR)peripheral blood inflammatory biomarker (PBIB)prognostic factorssurvival outcomes

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
  • Department of Head and Neck Surgery, Shanxi Provincial Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan,…
  • Department of Oral and Maxillofacial Surgery, Shanxi Provincial People's Hospital, The Fifth Clinical Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Stomatology, Tianjin Medical University General Hospital, Tianjin, China.
  • School of Stomatology, Shanxi Medical University, Taiyuan, China.
  • School of Public Health, Shanxi Medical University, Taiyuan, China.

Förderung

  • Natural Science Foundation of Shanxi Province
  • Health Commission of Shanxi Province

Zitieren

APA

Li, Z., An, W., Wang, B., Yan, Z., Gao, L., Wang, J., Yu, H., & Wen, S. (2025). Prognostic significance of peripheral blood inflammatory biomarkers (SII, PLR, NLR, LMR, SIRI, PIV, PNI) in lip cancer: NLR as an independent biomarker for survival outcomes. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1676824

Vancouver

Li Z, An W, Wang B, Yan Z, Gao L, Wang J, et al. Prognostic significance of peripheral blood inflammatory biomarkers (SII, PLR, NLR, LMR, SIRI, PIV, PNI) in lip cancer: NLR as an independent biomarker for survival outcomes. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1676824

BibTeX
@article{Li2025,
  author = {Li, Zhilin and An, Wei and Wang, Bin and Yan, Zening and Gao, Liangbin and Wang, Jiaming and Yu, Hongmei and Wen, Shuxin},
  title = {Prognostic significance of peripheral blood inflammatory biomarkers (SII, PLR, NLR, LMR, SIRI, PIV, PNI) in lip cancer: NLR as an independent biomarker for survival outcomes},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1676824}
}
Kostenlos starten →